These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
109 related articles for article (PubMed ID: 22309338)
41. [The tuberculid concept from the current viewpoint]. Braun-Falco O; Thomas P Hautarzt; 1995 Jun; 46(6):383-7. PubMed ID: 7642380 [TBL] [Abstract][Full Text] [Related]
42. Diagnosis of Ocular Tuberculosis. Ang M; Vasconcelos-Santos DV; Sharma K; Accorinti M; Sharma A; Gupta A; Rao NA; Chee SP Ocul Immunol Inflamm; 2018; 26(2):208-216. PubMed ID: 27379384 [TBL] [Abstract][Full Text] [Related]
43. Interferon-γ Release Assay and Reverse Blot Hybridization Assay: Diagnostic Role in Cutaneous Tuberculosis. Chung HC; Kim BK; Hong H; Wang HY; Kim Y; Lee H; Eom M; Choi EH Acta Derm Venereol; 2016 Jan; 96(1):126-7. PubMed ID: 26084370 [No Abstract] [Full Text] [Related]
44. Successful diagnosis and management of tuberculosis verrucosa cutis using antituberculosis therapy trial approach. Pebriany D; Anwar AI; Djamaludin W; Adriani A; Amin S Pan Afr Med J; 2020; 37():216. PubMed ID: 33520055 [TBL] [Abstract][Full Text] [Related]
45. Tuberculin skin test versus interferon-gamma release assays. Tin SS; Wiwanitkit V Acta Clin Belg; 2015 Apr; 70(2):157. PubMed ID: 25400219 [No Abstract] [Full Text] [Related]
46. Diagnostic Value of T-SPOT.TB Test in Cutaneous Mycobacterial Infections. Chen Y; Jiang H; Zhang W; Chen Z; Mei Y; Chen H; Shi Y; Gao W; Wang L; Chokkakula S; Wang H Acta Derm Venereol; 2018 Nov; 98(10):989-990. PubMed ID: 30085325 [No Abstract] [Full Text] [Related]
47. Challenges in the use of tests to diagnose tuberculosis infection. Marais BJ N S W Public Health Bull; 2013 Nov; 24(2):92-3. PubMed ID: 24195853 [No Abstract] [Full Text] [Related]
48. Challenges in the use of tests to diagnose tuberculosis infection. Dobler CC N S W Public Health Bull; 2013 Nov; 24(2):93. PubMed ID: 24195854 [No Abstract] [Full Text] [Related]
49. sQuiz your knowledge: Recurrent ulcerative skin nodules on the extremities. Yi S; Tu P; Wang Y Eur J Dermatol; 2018 Aug; 28(4):569-570. PubMed ID: 30396873 [No Abstract] [Full Text] [Related]
51. Status and current role of 'interferon gamma release assays' vs. 'tuberculin skin testing' in diagnosis of tubercular disease. Mukherjee A; Lodha R; Kabra SK Indian J Pediatr; 2013 Apr; 80(4):334-6. PubMed ID: 23381915 [No Abstract] [Full Text] [Related]
53. 50 Years Ago in The Journal of Pediatrics: Isoniazid Prophylaxis in Tuberculin Reactors. Starke J J Pediatr; 2018 Jan; 192():52. PubMed ID: 29246357 [No Abstract] [Full Text] [Related]
55. [Comparative analyses between tuberculids and extrapulmonary tuberculosis - Another face for Mycobacterium tuberculosis]. Barroso Pereira JC Rev Port Pneumol; 2008; 14(3):391-407. PubMed ID: 18528600 [TBL] [Abstract][Full Text] [Related]
56. [Advances in the application of interferon gamma release assay in controlling tuberculosis group infection]. Song QS; Lu XW Zhonghua Jie He He Hu Xi Za Zhi; 2013 Jan; 36(1):46-8. PubMed ID: 23537542 [No Abstract] [Full Text] [Related]
57. New developments on interferon-γ release assays for tuberculosis diagnosis. Arend SM; Uzorka JW Lancet Infect Dis; 2019 Feb; 19(2):121-122. PubMed ID: 30655048 [No Abstract] [Full Text] [Related]